omega-n-methylarginine has been researched along with atrial natriuretic factor in 32 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 15,455 | 1,105 | 1,760 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (59.38) | 18.2507 |
2000's | 11 (34.38) | 29.6817 |
2010's | 2 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billiar, TR; Curran, RD; Di Silvio, M; Harbrecht, BG; Murray, SA; Ochoa, JB; Simmons, RL; Stadler, J; Williams, DL | 1 |
Catravas, JD; Marczin, N; Ryan, US | 1 |
Aisaka, K; Hidaka, T; Ishihara, T; Kanai, T; Miyazaki, T; Ohno, T | 1 |
Christensen, G; Kiil, F; Kirkebøen, KA; Naess, PA | 1 |
Anggard, E; Mollace, V; Salvemini, D; Vane, J | 1 |
Levi, R; Park, KH | 1 |
Belova, N; Diaz, MC; Duvilanski, BH; Lasaga, M; McCann, SM; Pisera, D; Rettori, V; Seilicovich, A; Zambruno, C | 1 |
Hirahashi, J; Hishikawa, K; Kato, R; Marumo, T; Nakaki, T; Saruta, T; Suzuki, H | 1 |
Schulz, R; Vollmar, AM | 1 |
Kohan, DE; Padilla, E | 1 |
Barer, G; Bee, D; Emery, C; Howard, P; Stewart, A | 1 |
Burnett, JC; Miller, VM; O'Murchu, B; Perrella, MA | 1 |
Kurtz, A; Scholz, H | 1 |
Aoyama, T; Iimura, O; Iwata, M; Nomura, N; Shimamoto, K; Takagawa, Y; Ura, N | 1 |
Melo, LG; Sonnenberg, H | 1 |
Ikeda, U; Shimada, K; Yamamoto, K | 1 |
Calderone, A; Chang, DL; Colucci, WS; Takahashi, N; Thaik, CM | 1 |
Dijkhorst-Oei, LT; Koomans, HA | 1 |
Bech, JN; Nielsen, CB; Pedersen, EB; Svendsen, KB | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Ohhata, S; Sakane, T; Sano, K; Shimada, T; Sugamori, T; Takahashi, N | 1 |
Hobbs, AJ; Hussain, MB; MacAllister, RJ | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
Capponi, A; Giostra, E; Hadengue, A; Lang, U; Martin, PY; Niederberger, M; Spahr, L | 1 |
Evans, TW; Mitchell, JA; Price, S | 1 |
Broadley, AJ; Cockcroft, JR; Frenneaux, MP; Gunaruwan, P; Lee, L; Nightingale, AK; Payne, N; Schmitt, M; Struthers, AD; Taylor, J; Tyberg, JV | 1 |
Ueda, S; Umemura, S; Wada, A | 1 |
Antunes-Rodrigues, J; Cunha, FQ; Elias, LL; Giusti-Paiva, A; Gomes, DA; Reis, WL; Ventura, RR | 1 |
Bech, JN; Nielsen, EH; Pedersen, EB; Pedersen, RS; Svendsen, KB | 1 |
Huxley, VH; Sarelius, IH; Wang, JJ | 1 |
Burnett, JC; Chen, HH; Jougasaki, M; Martin, FL; Matsuda, Y; Sandberg, SM; Supaporn, T | 1 |
Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Starklint, J | 1 |
5 trial(s) available for omega-n-methylarginine and atrial natriuretic factor
Article | Year |
---|---|
Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Diet; Diuresis; Enzyme Inhibitors; Hemodynamics; Humans; Kidney; Lithium; Male; Metabolic Clearance Rate; Natriuresis; Nitric Oxide Synthase; omega-N-Methylarginine; Osmolar Concentration; Reference Values; Renin; Sodium | 1998 |
The systemic and renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lithium; Male; Nitric Oxide; omega-N-Methylarginine; Sodium | 1999 |
Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Topics: Administration, Oral; Adult; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic GMP; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Lithium; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation; Renin-Angiotensin System; Sodium; Sodium Chloride; Time Factors | 2007 |
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Flow Velocity; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance | 2013 |
27 other study(ies) available for omega-n-methylarginine and atrial natriuretic factor
Article | Year |
---|---|
Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Corynebacterium Infections; Cyclic GMP; Cytokines; Lipopolysaccharides; Liver; Nitric Oxide; Nitrous Oxide; omega-N-Methylarginine; Propionibacterium acnes | 1992 |
Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arginine; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Vasodilator Agents | 1992 |
Effects of nitric oxide-related compounds and carperitide on hemodynamics and hematocrit in anesthetized rats.
Topics: Anesthesia; Animals; Arginine; Atrial Natriuretic Factor; Blood Pressure; Erythrocytes; Heart Rate; Hematocrit; Hemodynamics; Male; Nitric Oxide; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Peptide Fragments; Rats; Rats, Wistar; Recombinant Proteins | 1992 |
Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
Topics: Acetylcholine; Animals; Arginine; Atrial Natriuretic Factor; Dogs; Female; Kidney; Male; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Renal Circulation | 1992 |
Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arginine; Atrial Natriuretic Factor; Blood Platelets; Cattle; Cyclic GMP; Cycloheximide; Escherichia coli; Guanylate Cyclase; Humans; In Vitro Techniques; Lipopolysaccharides; Macrophages; Mice; Monocytes; Muscle, Smooth; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Superoxide Dismutase; Thrombin | 1991 |
Hypoxic coronary vasodilatation and cGMP overproduction are blocked by a nitric oxide synthase inhibitor, but not by a guanylyl cyclase ANF receptor antagonist.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Atrial Natriuretic Factor; Coronary Circulation; Cyclic GMP; Guanylate Cyclase; Guinea Pigs; Humans; Hypoxia; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Polysaccharides; Receptors, Atrial Natriuretic Factor; Vasodilation | 1994 |
Role of nitric oxide in control of prolactin release by the adenohypophysis.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Atrial Natriuretic Factor; Cyclic GMP; Dibutyryl Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Guanylate Cyclase; Hemoglobins; In Vitro Techniques; Luteinizing Hormone; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1995 |
Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
Topics: Amino Acid Oxidoreductases; Animals; Antihypertensive Agents; Aorta; Arginine; Atrial Natriuretic Factor; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Interleukin-1; Kinetics; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Proteins; Rats; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1995 |
Atrial natriuretic peptide inhibits nitric oxide synthesis in mouse macrophages.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Cells, Cultured; Female; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; omega-N-Methylarginine; Rats | 1995 |
Endothelin-1 production by rat inner medullary collecting duct: effect of nitric oxide, cGMP, and immune cytokines.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Base Sequence; Cells, Cultured; Cyclic GMP; Dibutyryl Cyclic GMP; DNA Primers; Endothelins; Interferon-gamma; Kidney Medulla; Kidney Tubules, Collecting; Kinetics; Male; Molecular Sequence Data; Nitric Oxide; omega-N-Methylarginine; Penicillamine; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1994 |
Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats.
Topics: Almitrine; Animals; Arginine; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Endothelins; Endothelium, Vascular; Hypoxia; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Pulmonary Circulation; Rats; Rats, Wistar; Respiration; Vasoconstriction | 1993 |
Increased production of nitric oxide in coronary arteries during congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Atrial Natriuretic Factor; Azepines; Blood Pressure; Calcimycin; Cardiac Output; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Femoral Artery; Heart Failure; Hemodynamics; In Vitro Techniques; Indomethacin; Isometric Contraction; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Pertussis Toxin; Reference Values; Renal Artery; Renin; Vascular Resistance; Virulence Factors, Bordetella | 1994 |
Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.
Topics: Acetylcholine; Angiotensin I; Animals; Arginine; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; In Vitro Techniques; Isoproterenol; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Nitroprusside; omega-N-Methylarginine; Perfusion; Pressure; Rats; Rats, Inbred Strains; Renin | 1993 |
The mechanisms of the renal effects of neutral endopeptidase inhibitor in rats.
Topics: Adrenergic beta-Antagonists; Animals; Arginine; Atrial Natriuretic Factor; Bradykinin; Cyclic GMP; Cyclohexanecarboxylic Acids; Kidney; Kinins; Male; Neprilysin; Nitric Oxide; omega-N-Methylarginine; Protease Inhibitors; Rats; Rats, Sprague-Dawley | 1995 |
Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; In Vitro Techniques; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1996 |
Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Topics: Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Heart; Interleukin-1; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Kinases; Proteins; Rats; Rats, Sprague-Dawley | 1997 |
Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Topics: Adrenergic alpha-Agonists; Animals; Atrial Natriuretic Factor; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Fibroblasts; Heart; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Penicillamine; Protein Precursors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-fos; Rats; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Sarcoplasmic Reticulum; Thymidine; Tritium | 1998 |
Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; Muscle Tonus; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Severity of Illness Index; Vasomotor System | 2000 |
Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Homeostasis; Humans; Mammary Arteries; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrogen Oxides; Nitroglycerin; omega-N-Methylarginine; Phenylephrine; Solubility; Spermine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Analysis of Variance; Atrial Natriuretic Factor; Blood Flow Velocity; Case-Control Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Endothelium, Vascular; Female; Forearm; Guanidines; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Severity of Illness Index; Time Factors; Vasodilation | 2001 |
Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
Topics: Adult; Aged; Aspartate Aminotransferases; Atrial Natriuretic Factor; Dinoprostone; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Female; Hemodynamics; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation | 2002 |
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock.
Topics: Animals; Atrial Natriuretic Factor; Cell Death; Electric Stimulation; Enzyme Inhibitors; Heart; Heart Atria; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Culture Techniques; Rats; Salmonella enteritidis; Sepsis; Shock, Septic | 2002 |
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Peptide Fragments; Tetrahydroisoquinolines; Vascular Resistance; Vasodilation; Veins | 2004 |
Methodological validity and feasibility of the nitric oxide clamp technique for nitric oxide research in human resistant vessels.
Topics: Acetylcholine; Adult; Area Under Curve; Atrial Natriuretic Factor; Cardiology; Enzyme Inhibitors; Feasibility Studies; Forearm; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Plethysmography; Reference Values; Regional Blood Flow; Vascular Resistance; Vasodilation; Vasodilator Agents | 2004 |
The role of carbon monoxide and nitric oxide in hyperosmolality-induced atrial natriuretic peptide release by hypothalamus in vitro.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Carbon Monoxide; Citrulline; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hemoglobins; Hypothalamus; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; omega-N-Methylarginine; Osmolar Concentration; Potassium Chloride; Rats | 2004 |
Adaptation of coronary microvascular exchange in arterioles and venules to exercise training and a role for sex in determining permeability responses.
Topics: Adaptation, Physiological; Adenosine; Adenylyl Cyclases; Adrenergic beta-Agonists; Albumins; Animals; Arterioles; Atrial Natriuretic Factor; Capillary Permeability; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Physical Endurance; Research Design; Sex Factors; Signal Transduction; Swine; Swine, Miniature; Venules | 2007 |
Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.
Topics: Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Guanylate Cyclase; Heart Failure; Kidney; Male; omega-N-Methylarginine; Polysaccharides | 2007 |